Skip to main content

Study IDs Reference Levels for Serum Neurofilament Light Chain in Youth

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Aug. 8, 2023 -- Measures of serum neurofilament light chain (sNfL) clinically differentiate children with neurological conditions versus healthy children, according to a study published online July 28 in The Lancet Neurology.

Ahmed Abdelhak, M.D., from the University of California in San Francisco, and colleagues aimed to establish an age-adjusted sNfL reference range database in a population of 2,667 healthy children and adolescents (aged 0 to 22 years) and to validate the clinical applicability of this database in 220 pediatric patients (aged 1 to 19 years) with neurological conditions (epilepsy, traumatic brain injury, bacterial central nervous system infections, pediatric-onset multiple sclerosis, and myelin oligodendrocyte glycoprotein antibody-associated disease).

The researchers found that in the healthy population, sNfL concentrations decreased with age by an estimated 6.8 percent per year until age 10.3 years (estimated multiplicative effect per 1-year increase, 0.93; 95 percent confidence interval, 0.93 to 0.94; P < 0·0001) and was mostly stable thereafter up to age 22 years (1.00; 95 percent confidence interval, 0.52 to 1.94; P > 0.99). The magnitude of the effect of weight on sNfL concentrations was marginal and was independent of age. Among children with neurological conditions, age-adjusted sNfL z scores were higher versus healthy children and adolescents.

"Compared with absolute sNfL values, the use of sNfL z score was associated with higher effect size metrics and allowed for more accurate estimation of the extent of ongoing neuroaxonal damage in individual patients," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy

FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other...

Epilepsy Surgery for Neuroglial Tumors Shows Good Long-Term Outcomes

MONDAY, June 17, 2024 -- Patients with neuroglial tumors are ideal epilepsy surgical candidates, with good long-term outcomes observed, according to a study published online May...

In Utero Exposure to Antiseizure Meds Does Not Affect Child Creativity

WEDNESDAY, May 29, 2024 -- There are no differences in creative thinking at age 4.5 years for children of women with epilepsy (WWE) and children of healthy women (HW), but fetal...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.